Traditional Chinese medicine composition for treating upper respiratory infection

Abstract

The invention discloses a traditional Chinese medicine composition for treating upper respiratory infection. The traditional Chinese medicine composition comprises, by weight, 5-8 parts of rhizoma atractylodis, 2-5 parts of periostracum cicada, 3-5 parts of poria cocos, 1-3 parts of dahurian angelica root, 2-4 parts of divaricate saposhnikovia root, 5-7 parts of scutellaria baicalensis, 3-5 parts of dandelion, 2-4 parts of American ginseng, 5-7 parts of wrinkled giant hyssop, 8-10 parts of pumpkin flower, 3-5 parts of bitter orange, 2-4 parts of root of kudzu vine, 5-7 parts of leaf of Japanese raisin tree, 2-4 parts of towel gourd root, 3-5 parts of Lysimachia christinae Hance, 2-4 parts of Begonia fimbristipula Hance, 2-4 parts of flower of official magnolia, 1-2 parts of cactus, 4-5 parts of Herba Ophioglossi, 3-5 parts of root-bark of Chinese wolfberry, and 2-4 parts of sunflower leaf. Through scientific compatibility of the traditional Chinese medicines having different medicine properties, the traditional Chinese medicine composition has effects of strongly resisting viruses, relieving fever and diminishing inflammation, and improving immunity, is safe, has small toxic or side effects, is convenient for use, and realizes short cure time and difficult recurrence.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating upper respiratory tract infection, which belongs to the field of traditional Chinese medicines. Background technique [0002] Upper respiratory tract infection refers to the general term for acute inflammation from the nasal cavity to the throat. Its pathogens include bacteria, viruses, mycoplasma, chlamydia, etc., with different degrees of systemic symptoms and local symptoms such as rhinitis, pharyngitis, and tonsillitis. High, the crowd is generally susceptible, especially the elderly and infirm and young and sick or with chronic underlying diseases, the incidence of complications is high. At present, Western medicine mainly uses symptomatic treatment. satisfactory. Contents of the invention [0003] The object of the present invention is to provide a traditional Chinese medicine composition for treating upper respiratory tract infection. [0004] The present invent...

AI Technical Summary

Problems solved by technology

[0002] Upper respiratory tract infection refers to the general term for acute inflammation from the nasal cavity to the throat. Its pathogens include bacteria, viruses, mycoplasma, chlamydia, etc., with different degrees of systemic symptoms and local symptoms such as rhinitis, pharyngitis, and tonsillitis. High, the crowd is generally susceptible, especially the elderly and infirm and young and sick or with chronic underlying diseases, the incidence of complications is high. At present, Western medicine mainly uses symptomatic treatment. satisfactory